America Votes, China Plans
November 3, 2026
China sets out its stall for global biopharmaceutical preeminence as the US faces further uncertainty over research funding and regulation
23 min read
False
Advertisement
Top Stories
Browse By Topic
Newsletters
Receive the latest Medicine Maker news, personalities, education, and career development – weekly to your inbox.
Voices in the Community
The voices driving change and progress in medicine making. Explore stories, interviews, and community highlights that inspire and inform.
Bruce Levine
Barbara and Edward Netter Professor in Cancer Gene Therapy, University of Pennsylvania Perelman School of Medicine
View ProfileMusings from The Power List: Claudia Zylberberg
Claudia Zylberberg discusses building the infrastructure, partnerships, and policies needed to bring advanced therapies to patients at scale
Latest News
All the latest Medicine Maker articles.
Off-the-Shelf CAR T Shows Early Signal in Progressive Multiple Sclerosis
November 2, 2026
Phase I data show B-cell depletion and mostly stable or improved disability scores, but the uncontrolled study remains small and follow-up is limited
2 min read
The Challenge of Scaling Cell and Gene Therapy
October 30, 2026
Erik Vaessen on the costs, complexities, and technologies shaping advanced therapy manufacturing.
5 min read
Biopharma
Drug Delivery
Development & Clinical
Formulation
Interviews
Business & Trends
Sitting Down With
Staying the Course: Sitting Down With Mike Cooke
October 29, 2026
AmacaThera Co-Founder and CEO Mike Cooke reflects on the long road from academic discovery to a potential new treatment for post-operative pain
9 min read
Prime Editing Creates Drug-Controllable T Cell Therapies
October 28, 2026
Engineered T cells resisted tacrolimus but remained sensitive to cyclosporin, providing a potential way to select or suppress them after administration
2 min read
Engineering a New Generation of Cancer-Fighting Cells
October 28, 2026
USC researchers develop a scalable cell engineering platform that could overcome key manufacturing and therapeutic limitations of CAR-based immunotherapies
2 min read
Video: Leading the Alpha Charge – with Øystein Soug
October 28, 2026
From the Norwegian Air Force to alpha-emitting radiopharmaceuticals, Øystein Soug has taken the unconventional route to biotech leadership
1 min read
Amgen Expands Veeva Partnership
October 27, 2026
Global deployment of Veeva Vault CRM aims to help Amgen uncover treatment barriers and accelerate the delivery of new therapies
2 min read
Is Stem Cell Therapy Quality Control Missing Proteotoxic Cargo?
October 26, 2026
Review calls for senescence screening and EV proteomic profiling to assess whether cell therapy products can maintain protein homeostasis after transplantation
2 min read
Surviving the Squeeze
October 26, 2026
The 2026 Power List discuss strategies for navigating today’s funding landscape in cell and gene therapy
4 min read
Engineering CAR T Cells Inside Solid Tumors
October 26, 2026
Researchers develop targeted lipoplex platform that generates CAR T and NK cells directly within tumors, improving survival in preclinical breast cancer models
2 min read
Newsletters
Receive the latest Medicine Maker news, personalities, education, and career development – weekly to your inbox.